Long lasting anti-hemophilia factor safe in kids, experts say
Saturday, April 25, 2015 - 14:00
in Health & Medicine
Children with hemophilia A require three to four infusions each week to prevent bleeding episodes, chronic pain and joint damage. A new, extended therapy combines recombinant factor VIII with a fusion protein that allows the molecule to remain in the circulation longer -- translating into a need for less frequent treatment.